GRIFOLS | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Alcon AG USD 1.83B 112M 2024-12
Almirall EUR 329.41M 15.11M 2024-06
Amadeus IT EUR 1.05B 35.1M 2024-12
Amarin USD 156.94M 58.98M 2024-09
AstraZeneca USD 5.49B 691M 2024-12
Bayer EUR 6.19B 1.57B 2024-12
Cie Automotive EUR 947.45M 451.62M 2024-12
Demant 1.11B 64M 2024-12
Ence Energia y Celulosa EUR 318.8M 79.9M 2024-09
Essilor EUR 2.25B 86M 2024-12
Ferrovial EUR 4.81B 1.17B 2024-12
Fresenius EUR 2.28B 788M 2024-12
Fresenius Medical Care EUR 1.18B 191M 2024-12
Galapagos EUR 64.24M 8.72M 2024-12
Genmab DKK 9.86B 3.52B 2024-12
GlaxoSmithKline GBP 3.87B 678M 2024-12
GRIFOLS EUR 979.78M 334.84M 2024-12
Hikma Pharmaceutical USD 0 1000K 2024-06
Inditex EUR 6.38B 1.89B 2025-01
Merck EUR 2.15B 1.01B 2024-12
Novartis USD 8.87B 4.74B 2024-12
Philips EUR 2.4B 594M 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 6.8B 1.92B 2024-06
Smith & Nephew 568M 266M 2024-06
UCB EUR 1.57B 1.14B 2024-12
Viscofan EUR 55.14M 8.83M 2024-12



GRIFOLS Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.